Novelix Pharmaceuticals seeks approval to raise ₹6.84 crore via preferential issue
Published on: June 9, 2026, 7:27 p.m. | Source: scanx.trade
Novelix Pharmaceuticals Limited has called for an Extra Ordinary General Meeting on July 1, 2026, to approve the preferential allotment of 12,00,000 equity shares to 18 non-promoter investors at ₹57 per share, aggregating to ₹6.84 crore. The proceeds are earmarked for lab-scale technology transfer, land lease deposits, development, and equipment procurement. The record date for voting eligibility is June 24, 2026, with remote e-voting open from June 28 to June 30.
